Sonya VanPatten

Northwell Health — United States

Immunology and Microbiology · Life Sciences

15h-index1.6kcitations28works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Macrophage Migration Inhibitory Factor(6), Advanced Glycation End Products research(5), Regulation of Appetite and Obesity(3), Cholesterol and Lipid Metabolism(3), Biochemical effects in animals(3)

Publications28 total

Protease-Resistant Azapeptide GLP-1 Analogue Improves Metabolic Control in Diet-Induced Obesity
2025· 1 citedOpen Access
Multi-Drug Cocktail Therapy Improves Survival and Neurological Function after Asphyxial Cardiac Arrest in Rodents
Cells·2023· 5 citedOpen Access
CCDC 2195262: Experimental Crystal Structure Determination
The Cambridge Structural Database·2022Open Access
Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates
Nature Communications·2022· 15 citedOpen Access
CCDC 2195263: Experimental Crystal Structure Determination
The Cambridge Structural Database·2022Open Access
Azapeptides -A History of Synthetic Milestones and Key Examples
Current Medicinal Chemistry·2022· 15 cited
SARS-CoV-2 and interferon blockade
Molecular Medicine·2020· 3 citedOpen Access
Evidence Supporting the Use of Peptides and Peptidomimetics As Potential SARS-CoV-2 (COVID-19) Therapeutics
Future Medicinal Chemistry·2020· 64 citedOpen Access
Rediscovering MIF: New Tricks for an Old Cytokine
Trends in Immunology·2019· 75 cited
Mechanistic insights into high mobility group box-1 (HMGb1)-induced Toll-like receptor 4 (TLR4) dimer formation
Journal of Biomolecular Structure and Dynamics·2018· 28 cited
High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target
Journal of Medicinal Chemistry·2017· 102 citedOpen Access
A structural investigation of FISLE-412, a peptidomimetic compound derived from saquinavir that targets lupus autoantibodies
Bioorganic & Medicinal Chemistry Letters·2017· 11 cited
Effects of novel muscarinic M3 receptor ligand C1213 in pulmonary arterial hypertension models
Physiological Reports·2016· 9 citedOpen Access
The challenges of modulating the ‘rest and digest’ system: acetylcholine receptors as drug targets
Drug Discovery Today·2016· 14 cited
Amending HIV Drugs: A Novel Small-Molecule Approach To Target Lupus Anti-DNA Antibodies
Journal of Medicinal Chemistry·2016· 16 cited
Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death
European Journal of Pharmacology·2014· 11 cited
Novel Arylazoarylmethane as Potential Inhibitor of Macrophage Migration Inhibitory Factor
Archiv der Pharmazie·2013· 3 cited
Elaborate ligand-based modeling reveal new migration inhibitory factor inhibitors
Journal of Molecular Graphics and Modelling·2013· 19 cited
Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity
Proceedings of the National Academy of Sciences·2011· 50 cited
MIF as a Disease Target: ISO-1 as a Proof-of-Concept Therapeutic
Future Medicinal Chemistry·2010· 102 cited
page 1 of 2Next →

Frequent Co-authors

Yousef Al‐Abed(22), Mingzhu He(10), Kai Cheng(7), Thomas R. Coleman(7), Betty Diamond(6), Ahmad S. Altiti(5), David E. Cohen(4), Christine N. Metz(4), Kevin J. Tracey(4), Kirk R. Manogue(4), Bayan Al Jabari(4), Umair Ahmed(3), Pui Yan Chiu(3), Ibrahim T. Mughrabi(3), Ronald M. Burch(3), LaQueta Hudson(3), Stavros Zanos(3), Myoungsun Son(3), Barbara Sherry(3), Kai Fan Cheng(3)